HOUSTON, TEXAS — A two-year-old boy diagnosed with acute lymphoblastic leukemia (ALL) while on a family trip in Paris is now receiving specialized treatment at Texas Children’s Hospital in Houston, with doctors reporting steady progress.
John Jungels, the son of Kyle and Sarah Jungels, began experiencing flu-like symptoms during the family’s vacation. When his condition worsened, French doctors diagnosed him with ALL, a cancer of the blood and bone marrow that affects white blood cell production and compromises the immune system.
The diagnosis led to urgent decisions and international coordination. Due to his deteriorating health, John was unable to fly commercially. Texas Children’s Hospital’s International Team coordinated his medical transfer from France to Houston, managing communication between hospitals, insurance issues, and travel logistics.
Pediatric oncologist Dr. Lauren Sherer is leading John’s treatment. She cited recent advancements in personalized medicine for improving survival rates and outcomes for pediatric leukemia patients.
“With modern treatments, we can customize therapy, which is critical to both effectiveness and long-term quality of life,” she said.
At the time of his arrival in Houston, John could not walk or speak clearly. Six months into therapy, his condition has improved. He is now speaking more, learning new words, and engaging in play-based activities.
Kyle Jungels described the moment of diagnosis as devastating. “It felt like a death sentence,” he said. Sarah Jungels shared that she initially believed their son had a minor illness. Both parents credited early medical intervention and international cooperation for helping save their child’s life.
Dr. Sherer emphasized the importance of early detection and parental awareness. “Parents know their children best. If something feels wrong, they should continue asking questions,” she said.
As Pediatric Cancer Awareness Month continues, the Jungels family hopes their story raises awareness about early diagnosis, global collaboration, and the importance of accessible pediatric cancer care.
John continues treatment with a hopeful outlook. His parents remain optimistic that he will complete therapy and live a healthy life.
